Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic fibroblast growth factor inhibits osteoclast-like cell formation

E Jimi1, T Shuto, T Ikebe

  • 1Department of Biochemistry, Faculty of Dentistry, Kyushu University, Fukuoka, Japan.

Journal of Cellular Physiology
|August 1, 1996
PubMed
Summary

Basic fibroblast growth factor (bFGF) inhibits osteoclast formation by targeting stromal cells, not osteoclast progenitors. This finding reveals a key mechanism in bone remodeling regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.

Scientific reports·2014
Same author

Mineral trioxide aggregate inhibits osteoclastic bone resorption.

Journal of dental research·2011
Same author

The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma.

Oral diseases·2011
Same author

Parathyroid-hormone-related protein induces expression of receptor activator of NF-{kappa}B ligand in human periodontal ligament cells via a cAMP/protein kinase A-independent pathway.

Journal of dental research·2005
Same author

The molecular basis of osteoclast differentiation and activation.

Novartis Foundation symposium·2001
Same author

NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development.

Immunity·2000

Area of Science:

  • Cell Biology
  • Biochemistry
  • Osteology

Background:

  • Osteoclast formation is crucial for bone remodeling.
  • Stromal cells and osteoblastic cells play a supportive role in osteoclast development.
  • Basic fibroblast growth factor (bFGF) is a cytokine with known roles in cell growth and differentiation.

Purpose of the Study:

  • To investigate the role of bFGF in osteoclast-like cell formation.
  • To identify the specific cellular targets of bFGF's inhibitory effects on osteoclastogenesis.
  • To elucidate the mechanism by which bFGF influences osteoclast differentiation.

Main Methods:

  • Co-culture of mouse bone marrow cells with ST2 stromal cells or primary osteoblastic cells.
  • Induction of osteoclast-like cell formation using 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, and interleukin-11.

Related Experiment Videos

  • Assessment of [3H] thymidine uptake and alkaline phosphatase activity in ST2 cells.
  • Methylcellulose culture to evaluate progenitor cell proliferation.

    • Main Results:

    • bFGF significantly inhibited osteoclast-like cell formation induced by various factors.
    • bFGF treatment increased [3H] thymidine uptake and decreased alkaline phosphatase-positive cells in ST2 cells.
    • bFGF did not affect progenitor cell proliferation or colony formation induced by macrophage colony stimulating factor.
    • bFGF's inhibitory effect on osteoclast formation appears to target stromal/osteoblastic cells, not osteoclast progenitors.

    Conclusions:

    • bFGF inhibits osteoclast-like cell formation by acting on stromal cells (e.g., ST2) and osteoblastic cells.
    • The mechanism involves inhibiting the differentiation of osteoclast progenitors rather than affecting progenitor proliferation.
    • bFGF targets a common pathway in osteoclast formation irrespective of the inducing agent.